Symbol | Name | Grade | Market Cap | Country |
---|---|---|---|---|
300122.CN | Chongqing Zhifei Biological Products Co. | 81.2 | ¤17,253 | CN |
000999.CN | China Resources Sanjiu Medical & Pharmac | 70.3 | ¤7,317 | CN |
002252.CN | Shanghai RAAS Blood Products Co., Ltd. C | 66.0 | ¤6,694 | CN |
600161.CN | Beijing Tiantan Biological Products Corp | 73.3 | ¤6,437 | CN |
002422.CN | Sichuan Kelun Pharmaceutical Co., Ltd. C | 61.0 | ¤6,296 | CN |
Symbol | Name | Grade | Market Cap | Country |
---|---|---|---|---|
600833.CN | Shanghai No. 1 Pharmacy Co. Ltd. Class A | 52.8 | ¤321 | CN |
603309.CN | WELL LEAD MEDICAL CO LTD Class A | 46.4 | ¤466 | CN |
300314.CN | Ningbo David Medical Device Co., Ltd. Cl | 52.8 | ¤477 | CN |
300206.CN | Edan Instruments, Inc. Class A | 41.6 | ¤784 | CN |
000915.CN | Shandong Wit Dyne Health Co., Ltd. Class | 78.9 | ¤1,070 | CN |
Symbol | Name | Grade | Times* | Country |
---|---|---|---|---|
000999.CN | China Resources Sanjiu Medical & Pharmac | 70.3 | 15 | CN |
600566.CN | HUBEI JUMPCAN PHARMACEUTICAL CO., LTD Cl | 68.7 | 15 | CN |
002252.CN | Shanghai RAAS Blood Products Co., Ltd. C | 66.0 | 14 | CN |
600161.CN | Beijing Tiantan Biological Products Corp | 73.3 | 14 | CN |
000915.CN | Shandong Wit Dyne Health Co., Ltd. Class | 78.9 | 11 | CN |
300122.CN | Chongqing Zhifei Biological Products Co. | 81.2 | 11 | CN |
002223.CN | Jiangsu Yuyue Medical Equipment & Supply | 70.5 | 10 | CN |
002262.CN | Jiangsu Nhwa Pharmaceutical Co., Ltd. Cl | 72.6 | 9 | CN |
002737.CN | Sunflower Pharmaceutical Group Co., Ltd. | 83.6 | 9 | CN |
300009.CN | Anhui Anke Biotechnology (Group) Co., Lt | 75.4 | 9 | CN |
Average Market Cap | ¤3,457 |
Median Market Cap | ¤2,246 |
Avg. 3 Mo. Dollar Vol. | ¤27,500,498 |
Avg. 3 Mo. Trading Vol. | 8,955,010 |
Last Rebalance Date | 06/12/2023 |
Companies Replaced | 13 |
Biggest Industry Increase | Health Care |
Biggest Industry Decrease | Health Care |
Trailing P/E Ratio (12 Mo.) | 18.2 |
Forward P/E Ratio (12 Mo.) | 19.5 |
Price/Book Ratio | 3.0 |
Avg. Revenue Chg. - 3 Yr | 58.2% |
Avg. Op. Income Chg. - 3 Yr. | 82.1% |
Avg. EPS Growth - 3 Yr. | 24.6% |
Avg. EPS Growth - 1 Yr. | 23.4% |
Avg. Operating Margin | 19.6% |
Avg. LT Debt to Total Capital | 9.1% |
Avg. Return on Equity | 16.6% |
Dividend Yield | 2% |
MarketGrader China A-Shares Health Care 30 Index | 62.21 |
China | 100.0% |